Business
Neuren initiates development of NNZ-2591 to treat HIE
Neuren initiates development of NNZ-2591 to treat HIE
About this update from Neuren Pharmaceuticals Limited
[{"type":"text","content":"Neuren Pharmaceuticals Ltd has released a press release. View Attachment","length":250,"tagName":"div"}]